<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.180252.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Opinion Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>A hypothesis: FN3KRP (Fructosamine-3-Kinase-Related Protein) phosphorylates intermediates downstream from fructosamines in the pathway leading from glucose to glucosepane.</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Szwergold</surname>
                        <given-names>Benjamin</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-0685-9890</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Research, Seroclear LLC, Philadelpia, PA, 19106, USA</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:seroclearllc@seroclear.org">seroclearllc@seroclear.org</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>5</month>
                <year>2026</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2026</year>
            </pub-date>
            <volume>15</volume>
            <elocation-id>713</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>28</day>
                    <month>4</month>
                    <year>2026</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2026 Szwergold B</copyright-statement>
                <copyright-year>2026</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/15-713/pdf"/>
            <abstract>
                <p>Fructosamine-3-kinase is a deglycating enzyme that reverses the glycation reaction by phosphorylating the first stable Maillard intermediate, fructosamine, to fructosamine-3-phosphate, thereby causing decomposition of that glycation adduct.</p>
                <p>In this paper I propose that a close homolog of that kinase, fructosamine-3-phosphate-related protein, phosphorylates 3-ketosamine, a Maillard intermediate downstream from fructosamine, to 3-ketosamine-4-phosphate. This phosphorylation causes decomposition of the 3-ketosamine intermediate, providing thereby another mechanism for reversing the Maillard reaction.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>FN3K</kwd>
                <kwd>FN3KRP</kwd>
                <kwd>glycation</kwd>
                <kwd>deglycation</kwd>
                <kwd>glucosepane</kwd>
                <kwd>Maillard reaction</kwd>
                <kwd>fructosamine</kwd>
                <kwd>ketosamine</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Nonenzymatic reactions between glucose and proteins (Maillard reactions) are an unavoidable feature of life. These reactions have mostly adverse effects on proteins by inhibiting enzymes, interfering with receptor function, and crosslinking structural proteins such as collagen.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>,
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> Traditionally, these reactions were thought to be totally nonenzymatic with no mechanisms to reverse or control them. This changed in the year 2000 with the discovery of Fructosamine-3-Kinase (FN3K)
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>,
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
            </p>
            <p>This enzyme phosphorylates the first stable intermediates of the Maillard reaction, protein-bound fructosamines, to fructosamine-3-phosphates. Since these phosphoesters are intrinsically unstable, this reaction leads to decomposition of the glycation adducts, regeneration of an unmodified protein, and concomitant production of 3-deoxyglucosone.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
            </p>
            <p>When FN3K was isolated in our laboratory, it copurified with another closely related protein that has an identical MW but a slightly lower isoelectric point (
                <xref ref-type="fig" rid="f1">Fig. 1</xref>).
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> At the time, this second protein was assumed to be an isozyme of FN3K with the same substrate specificity, namely D-fructosamine. Subsequent work revealed, however, that this enzyme, renamed Frucose-3-Kinase-Related Protein (FN3KRP), is quite distinct from FN3K because it does not phosphorylate D-fructosamines. Extensive work by Van-Schaftingen et al. has shown that FN3KRP phosphorylates a number of other Amadori products on the C3-hydroxyl. These include D-erythrulosamine, D-ribulosamine and D-psicosamine.
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> While none of these ketosamines, nor their aldose precursors, are found in cells, Van Schaftingen et al. have suggested and documented ways in which they can be produced from erythrose-4-phosphate and ribose-5-phosphate by a combination of Maillard reactions of the phosphorylated metabolites and dephosphorylation of the resulting Amadori products by specific phosphatases.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>,
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup>
            </p>
            <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                <label>Fig. 1. </label>
                <caption>
                    <title> A) Activity of the purified proteins with an Amadori substrate preparation containing 95% fructosamine and small amounts of other materials.</title>
                    <p>The assay was conducted by measuring the incorporation of 
                        <sup>32</sup>P into the product from 
                        <sup>32</sup>P ATP. 
                        <bold>B) SDS PAGE of fractions from an isoelectric-focusing gel showing the IEF isoforms of FN3K and FN3KRP corresponding to the activity profile shown in panel A.</bold>
                    </p>
                </caption>
                <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/198849/9cc6bc5e-18f5-4de2-8d13-f6654234a15c_figure1.gif"/>
            </fig>
            <p>Subsequent to Van Schaftingen&#x2019;s work, using recombinant FN3KRP, I was able to show that, in addition to the compounds identified above, FN3KRP also phosphorylates glucitolamines such as N-methylglucamine (meglumine).
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> However, unlike the other substrates, this phosphorylation occurs on the C4-hydroxyl. This was a surprising result, the significance of which was not apparent until a recent closer re-examination of data on purified FN3K, as shown in 
                <xref ref-type="fig" rid="f1">Fig.1</xref>. As can be seen in figure, phosphorylating activities are evident with both FN3K and FN3KRP, even though the substrate used here is nominally just fructosamine. The activity of FN3K is easy to understand; however, the source of FN3KRP activity is not clear.</p>
            <p>The most likely explanation for the phosphorylating activity of FN3KRP is that while the substrate used was nominally fructosamine, it was not completely homogeneous. As assessed at that time, it was only 95% pure but it probably also contained a compound (or compounds) that would be a substrate for FN3KRP. Given that the radioassay for FN3K used in these experiments contained saturating concentrations of fructosamine (1&#x00a0;mM vs. Km&#x00a0;~&#x00a0;25&#x00a0;&#x03bc;M), it is likely that the FN3KRP substrate, even if present as only a small fraction in this preparation, would be phosphorylated sufficiently (by FN3KRP) to be detected.</p>
            <p>Several candidates for the identity of this &#x201c;contaminant&#x201d; substrate are shown in 
                <xref ref-type="fig" rid="f2">Fig. 2</xref>, including the following:
                <list list-type="roman-upper">
                    <list-item>
                        <label>I)</label>
                        <p>A Schiff base of the amine with glucose</p>
                    </list-item>
                    <list-item>
                        <label>II)</label>
                        <p>A di-fructosamine adduct</p>
                    </list-item>
                    <list-item>
                        <label>III)</label>
                        <p>A glycation intermediate downstream of fructosamine, namely 3-keto-D-glucitolamine.</p>
                    </list-item>
                </list>
            </p>
            <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                <label>Fig. 2. </label>
                <caption>
                    <title>

                        <bold>Structures of the possible contaminants of the fructosamine substrate which could, hypothetically, be substrates of FN3KR.</bold>
</title>
                </caption>
                <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/198849/9cc6bc5e-18f5-4de2-8d13-f6654234a15c_figure2.gif"/>
            </fig>
            <sec id="sec2">
                <title>Hypothesis</title>
                <p>I propose that the physiological substrate of FN3KRP is 3-keto-D-glucolamine (3-ketosamine) produced from fructosamine by migration of the C2-carbonyl to the C3 position (
                    <xref ref-type="fig" rid="f3">Fig. 3</xref>), The product of this reaction, 3-ketosamine-4-phosphate, is intrisically unstable and decomposes to regenerate an unmodified protein along with a concomitant production of a tricarbonyl, 5,6-dihydoxy-2,3-dioxohexanal (
                    <xref ref-type="fig" rid="f4">Fig. 4</xref>).</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Fig. 3. </label>
                    <caption>
                        <title>

                            <bold>Some initial steps in the reaction between an amine and glucose leading from a Schiff base to fructosamine, then to 3-ketosamine and eventually to glucosepane.</bold>
</title>
                        <p/>
                    </caption>
                    <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/198849/9cc6bc5e-18f5-4de2-8d13-f6654234a15c_figure3.gif"/>
                </fig>
                <fig fig-type="figure" id="f4" orientation="portrait" position="float">
                    <label>Fig. 4. </label>
                    <caption>
                        <title>Proposed function of FN3KRP as a deglycating enzyme.</title>
                        <p>

                            <bold>A</bold>) 3-ketosamine is phosphdrylated by FN3KRP to 3-ketosamine-4-phosphate. 
                            <bold>B</bold>) Due to its structure, 3-ketosamine-4-phosphate decomposes by-elimination of phosphate to 4-deoxy-3-ketosamine. 
                            <bold>C</bold>) In a reverse Schiff reaction, 4-deoxy-3-ketosamine dissociates to an unmodified amine (protein) along with the production of a tricarbobyl, 4,5-dihydroxy-2,3-dioxohexanal (compound 
                            <bold>D</bold>). This tricarbonyl group is then reduced to 4-deoxyglucosone (compound 
                            <bold>E</bold>) and/or oxidized to 4-deoxy-2,3-dioxogluuconic acid (compound 
                            <bold>F</bold>).</p>
                    </caption>
                    <graphic id="gr4" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/198849/9cc6bc5e-18f5-4de2-8d13-f6654234a15c_figure4.gif"/>
                </fig>
            </sec>
            <sec id="sec3">
                <title>Support for the hypothesis</title>
                <p>

                    <list list-type="alpha-upper">
                        <list-item>
                            <label>A)</label>
                            <p>Based on the work of Lederer et al.,
                                <sup>
                                    <xref ref-type="bibr" rid="ref9">9</xref>,
                                    <xref ref-type="bibr" rid="ref10">10</xref>
                                </sup> it is clear that during the Maillard reaction of glucose with an amine, the carbonyl moieties of the sugar migrate rapidly along its backbone from C2 to C3 and onwards. Thus, it is very likely that in an Amadori preparation, synthesized by condensation of an amine with glucose, some ketosamines with C3, C4, C5, and C6 carbonyls will be present. Since 3-ketosamine (&#x2212;3-ketohexitolamine) is a glycation intermediate directly downstream of fructosamine, it is a good candidate as a substrate for FN3KRP and would be phosphorylated at C4.</p>
                        </list-item>
                        <list-item>
                            <label>B)</label>
                            <p>Given the ability of FN3KR to phosphorylate N-glucitolamines on the C4 hydroxyl, its suggested function as a 4-kinase of 3-ketosamines is consistent with the fact that its close homolog, FN3K, acts as a 3-kinase not only with fructosamines but also with glucitols and glucitol amines.
                                <sup>
                                    <xref ref-type="bibr" rid="ref8">8</xref>,
                                    <xref ref-type="bibr" rid="ref11">11</xref>&#x2013;
                                    <xref ref-type="bibr" rid="ref13">13</xref>
                                </sup>
                            </p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec4">
                <title>Experimental confirmations of the hypothesis</title>
                <p>

                    <list list-type="alpha-upper">
                        <list-item>
                            <label>A)</label>
                            <p>Testing this hypothesis should be straightforward, requiring only the synthesis of an Amadori product using glucose and an amine and the use of recombinant KN3KRP produced in HEK193 cells.
                                <sup>
                                    <xref ref-type="bibr" rid="ref14">14</xref>,
                                    <xref ref-type="bibr" rid="ref15">15</xref>
                                </sup> Since FN3KRP does not phosphorylate fructosamines, a reaction of the recombinant enzyme with high concentrations of the Amadori product (~ 50&#x00a0;mM) is likely to result in the phosphorylation of a small amount of substrate present in the preparation. The 
                                <sup>1</sup>H decoupled 
                                <sup>31</sup>P NMR spectrum of the reaction mixture revealed several peaks attributed only to the phosphorylated substrate. In the proton-coupled 
                                <sup>31</sup>P NMR spectrum, these peaks split into doublets with a coupling constant of ~10&#x00a0;Hz.</p>
                        </list-item>
                        <list-item>
                            <label>B)</label>
                            <p>Secondary tests of the hypothesis will involve determination of the decomposition rates of the phosphorylated substrate(s) and identification of byproducts that should include tricarbonyl (5,6-dihydroxy-2,3-dioxohexanal) as well as its reduced and oxidized metabolites, 4-deoxyglucosone and 4-deoxy-2,3-dioxogluconic acid (
                                <xref ref-type="fig" rid="f4">Fig.4</xref>).</p>
                        </list-item>
                    </list>
                </p>
                <p>

                    <underline>Reservations about the hypothesis</underline>
                </p>
                <p>There is little doubt that the Maillard reaction between an amine and glucose produces substrate(s) for FN3KRP. However, even if that compound is not 3-ketosamine, identifying the physiological substrate of FN3KRP is still worthwhile.</p>
                <p>

                    <underline>Implications</underline>
                </p>
                <p> If my hypothesis proves correct, then, at the very least, it will provide some new insights into the process of intracellular Maillard reactions and their control. Moreover, given the number of recent publications linking FN3KRP to a number of interesting phenotypes,
                    <sup>
                        <xref ref-type="bibr" rid="ref16">16</xref>&#x2013;
                        <xref ref-type="bibr" rid="ref21">21</xref>
                    </sup> the potential impact of this finding may prove to be substantial.</p>
            </sec>
        </sec>
    </body>
    <back>
        <sec id="sec7" sec-type="data-availability">
            <title>Data availability statement</title>
            <p>No data are associated with this article.</p>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Henning</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Glomb</surname>
                            <given-names>MA</given-names>
                        </name>
</person-group>:
                    <article-title>Pathways of the Maillard reaction under physiological conditions.</article-title>
                    <source>

                        <italic toggle="yes">Glycoconjugate journal.</italic>
</source>
                    <year>2016</year>;<volume>33</volume>(<issue>4</issue>):<fpage>499</fpage>&#x2013;<lpage>512</lpage>.
                    <pub-id pub-id-type="pmid">27291759</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10719-016-9694-y</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tessier</surname>
                            <given-names>FJ</given-names>
                        </name>
</person-group>:
                    <article-title>The Maillard reaction in the human body. The main discoveries and factors that affect glycation.</article-title>
                    <source>

                        <italic toggle="yes">Pathologie Biologie.</italic>
</source>
                    <year>2010</year>;<volume>58</volume>(<issue>3</issue>):<fpage>214</fpage>&#x2013;<lpage>219</lpage>.
                    <pub-id pub-id-type="pmid">19896783</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.patbio.2009.09.014</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Delpierre</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rider</surname>
                            <given-names>MH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Collard</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Identification, cloning, and heterologous expression of a mammalian fructosamine-3- kinase.</article-title>
                    <source>

                        <italic toggle="yes">Diabetes.</italic>
</source>
                    <year>2000</year>;<volume>49</volume>(<issue>10</issue>):<fpage>1627</fpage>&#x2013;<lpage>1634</lpage>.
                    <pub-id pub-id-type="doi">10.2337/diabetes.49.10.1627</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Szwergold</surname>
                            <given-names>BS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Howell</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Beisswenger</surname>
                            <given-names>PJ</given-names>
                        </name>
</person-group>:
                    <article-title>Human fructosamine-3- kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.</article-title>
                    <source>

                        <italic toggle="yes">Diabetes.</italic>
</source>
                    <year>2001</year>;<volume>50</volume>(<issue>9</issue>):<fpage>2139</fpage>&#x2013;<lpage>2147</lpage>.
                    <pub-id pub-id-type="doi">10.2337/diabetes.50.9.2139</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Collard</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Delpierre</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Stroobant</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.</article-title>
                    <source>

                        <italic toggle="yes">Diabetes.</italic>
</source>
                    <year>2003</year>;<volume>52</volume>(<issue>12</issue>):<fpage>2888</fpage>&#x2013;<lpage>2895</lpage>.
                    <pub-id pub-id-type="doi">10.2337/diabetes.52.12.2888</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fortpied</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gemayel</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vertommen</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Identification of protein-ribulosamine-5-phosphatase as human low-molecular-mass protein tyrosine phosphatase-A.</article-title>
                    <source>

                        <italic toggle="yes">Biochem J.</italic>
</source>
                    <year>2007</year>;<volume>406</volume>(<issue>1</issue>):<fpage>139</fpage>&#x2013;<lpage>145</lpage>.
                    <pub-id pub-id-type="pmid">17472574</pub-id>
                    <pub-id pub-id-type="doi">10.1042/BJ20061485</pub-id>
                    <pub-id pub-id-type="pmcid">PMC1948995</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gemayel</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fortpied</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rzem</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.</article-title>
                    <source>

                        <italic toggle="yes">The FEBS Journal.</italic>
</source>
                    <year>2007</year>;<volume>274</volume>(<issue>17</issue>):<fpage>4360</fpage>&#x2013;<lpage>4374</lpage>.
                    <pub-id pub-id-type="pmid">17681011</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1742-4658.2007.05948.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Szwergold</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Manevich</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Payne</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Fructosamine-3-kinase- related-protein phosphorylates glucitolamines on the C-4 hydroxyl: Novel substrate specificity of an enigmatic enzyme.</article-title>
                    <source>

                        <italic toggle="yes">Biochem Biophys Res Commun.</italic>
</source>
                    <year>2007</year>;<volume>361</volume>(<issue>4</issue>):<fpage>870</fpage>&#x2013;<lpage>875</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.07.127</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Biemel</surname>
                            <given-names>KM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Conrad</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lederer</surname>
                            <given-names>MO</given-names>
                        </name>
</person-group>:
                    <article-title>Unexpected carbonyl mobility in aminoketoses: the key to major Maillard crosslinks.</article-title>
                    <source>

                        <italic toggle="yes">Angew Chem Int Ed Engl.</italic>
</source>
                    <year>2002</year>;<volume>41</volume>(<issue>5</issue>):<fpage>801</fpage>&#x2013;<lpage>804</lpage>.</mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Reihl</surname>
                            <given-names>O</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rothenbacher</surname>
                            <given-names>TM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lederer</surname>
                            <given-names>MO</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Carbohydrate carbonyl mobility&#x2013;&#x2013;the key process in the formation of &#x03b1;-dicarbonyl intermediates.</article-title>
                    <source>

                        <italic toggle="yes">Carbohydrate research.</italic>
</source>
                    <year>2004</year>;<volume>339</volume>(<issue>9</issue>):<fpage>1609</fpage>&#x2013;<lpage>1618</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.carres.2004.03.024</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Petersen</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Szwergold</surname>
                            <given-names>BS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kappler</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes.</article-title>
                    <source>

                        <italic toggle="yes">J Biol Chem.</italic>
</source>
                    <year>1990</year>;<volume>265</volume>(<issue>29</issue>):<fpage>17424</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Petersen</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kappler</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Szwergold</surname>
                            <given-names>BS</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Fructose metabolism in the human erythrocyte. Phosphorylation to fructose 3-phosphate.</article-title>
                    <source>

                        <italic toggle="yes">Biochemical Journal.</italic>
</source>
                    <year>1992</year>;<volume>284</volume>(<issue>2</issue>):<fpage>363</fpage>&#x2013;<lpage>366</lpage>.
                    <pub-id pub-id-type="pmid">1599419</pub-id>
                    <pub-id pub-id-type="doi">10.1042/bj2840363</pub-id>
                    <pub-id pub-id-type="pmcid">PMC1132646</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Delpierre</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vanstapel</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Stroobant</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Conversion of a synthetic fructosamine into its 3-phospho derivative in human erythrocytes.</article-title>
                    <source>

                        <italic toggle="yes">Biochem J.</italic>
</source>
                    <year>2000</year>;<volume>352</volume>(<issue>3</issue>):<fpage>835</fpage>&#x2013;<lpage>839</lpage>.
                    <pub-id pub-id-type="doi">10.1042/bj3520835</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="other">
                    <ext-link ext-link-type="uri" xlink:href="https://www.bosterbio.com/ketosamine-3-kinase-fn3krp-nm-024619-human-recombinant-protein-protq9ha64-boster.html?srsltid=AfmBOorxlA99JKgsFFrl4L8yUjQDMqm-gctYFW5R8piQKPqpZT58vpfi">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="other">
                    <ext-link ext-link-type="uri" xlink:href="https://www.origene.com/catalog/proteins/recombinant-proteins/tp504379-fn3krp-nm-181420-mouse-recombinant-protein">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Alderawi</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Caramori</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Baker</surname>
                            <given-names>EH</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease.</article-title>
                    <source>

                        <italic toggle="yes">BMJ Open Respir Res.</italic>
</source>
                    <year>2020</year>;<volume>7</volume>(<issue>1</issue>).
                    <pub-id pub-id-type="doi">10.1136/bmjresp-2020-000714</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Benton</surname>
                            <given-names>MC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lea</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Macartney-Coxson</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Mapping eQTLs in the Norfolk Island genetic isolate identifies candidate genes for CVD risk traits.</article-title>
                    <source>

                        <italic toggle="yes">The American Journal of Human Genetics.</italic>
</source>
                    <year>2013</year>;<volume>93</volume>(<issue>6</issue>):<fpage>1087</fpage>&#x2013;<lpage>1099</lpage>.
                    <pub-id pub-id-type="pmid">24314549</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.11.004</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3853002</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kwon</surname>
                            <given-names>MJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kim</surname>
                            <given-names>JH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>JY</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Genetic Polymorphisms in the 3&#x2032;- Untranslated Regions of SMAD5, FN3KRP, and RUNX-1 Are Associated with Recurrent Pregnancy Loss.</article-title>
                    <source>

                        <italic toggle="yes">Biomedicines.</italic>
</source>
                    <year>2022</year>;<volume>10</volume>(<issue>7</issue>):<fpage>1481</fpage>.
                    <pub-id pub-id-type="pmid">35884785</pub-id>
                    <pub-id pub-id-type="doi">10.3390/biomedicines10071481</pub-id>
                    <pub-id pub-id-type="pmcid">PMC9313017</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cheng</surname>
                            <given-names>YF</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yang</surname>
                            <given-names>CY</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tsai</surname>
                            <given-names>MC</given-names>
                        </name>
</person-group>:
                    <article-title>Shared Genetics between Age at Menarche and Type 2 Diabetes Mellitus: Genome-Wide Genetic Correlation Study.</article-title>
                    <source>

                        <italic toggle="yes">Biomedicines.</italic>
</source>
                    <year>2024</year>;<volume>12</volume>(<issue>1</issue>):<fpage>157</fpage>.
                    <pub-id pub-id-type="pmid">38255262</pub-id>
                    <pub-id pub-id-type="doi">10.3390/biomedicines12010157</pub-id>
                    <pub-id pub-id-type="pmcid">PMC10813301</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Torres</surname>
                            <given-names>GG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nygaard</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Caliebe</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Exome-wide association study identifies FN3KRP and PGP as new candidate longevity genes.</article-title>
                    <source>

                        <italic toggle="yes">J Gerontol A Biol Sci Med Sci.</italic>
</source>
                    <year>2021</year>;<volume>76</volume>(<issue>5</issue>):<fpage>786</fpage>&#x2013;<lpage>795</lpage>.</mixed-citation>
            </ref>
            <ref id="ref21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shrestha</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Taujale</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Katiyar</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Multi-omics reveals new links between Fructosamine-3-Kinase (FN3K) and core metabolic pathways.</article-title>
                    <source>

                        <italic toggle="yes">NPJ Syst Biol Appl.</italic>
</source>
                    <year>2024</year>;<volume>10</volume>(<issue>1</issue>):<fpage>64</fpage>.</mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report485258">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.198849.r485258</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Loomes</surname>
                        <given-names>Kerry</given-names>
                    </name>
                    <xref ref-type="aff" rid="r485258a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r485258a1">
                    <label>1</label>University of Auckland, Auckland, New Zealand</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>9</day>
                <month>6</month>
                <year>2026</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2026 Loomes K</copyright-statement>
                <copyright-year>2026</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport485258" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.180252.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Unfortunately, this manuscript does not move knowledge forward from the author's previous peer-reviewed paper. In 2021, the author published a highly similar paper titled: 
                <italic>"A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines" </italic>in the journal,&#x00a0;Rejuvenation Research.</p>
            <p> </p>
            <p> The submitted manuscript is essentially a restatement of the same downstream phosphorylation model in this 2021 paper without any clear differentiation. This precludes indexing in its present form.</p>
            <p> </p>
            <p> The manuscript correctly identifies the core issue of non-enzymatic glycation (the Maillard reaction) and the physiological necessity of deglycation pathways to neutralize macromolecular damage caused by chronic hyperglycemia. The evolutionary preservation of FN3K and FN3KRP as ancient housekeeping genes across diverse taxa is consistent with literature highlighting cell maintenance roles.</p>
            <p> </p>
            <p> The primary scientific deficiency in this manuscript is its failure to properly context-shift from the author's previous peer-reviewed literature. In 2021, the author published a highly similar paper titled: "A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines".&#x00a0; This paper was not cited in the submitted manuscript.</p>
            <p> </p>
            <p> Comparing the submitted manuscript to this published 2021 paper, the text reveals significant overlap in conceptual framing, wording, and figures. Specifically, Figure 4 in the manuscript is essentially the same as Figure 4 in the 2021 publication. &#x00a0;To progress this hypothesis paper toward indexing, this opinion article should provide a distinct advancement, updated perspective, or newly emerging data to justify its indexing. Re-hypothesizing the same downstream phosphorylation model without clear differentiation compromises its standing in the current literature. There must be a clear differentiation from the paper published in 
                <italic>Rejuvenation Research</italic>&#x00a0;(2021) and the naming nomenclature used should also be consistent across the publications as well as incorporation of appropriate reference citations.</p>
            <p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p>
            <p>Partly</p>
            <p>Are arguments sufficiently supported by evidence from the published literature?</p>
            <p>Partly</p>
            <p>Are all factual statements correct and adequately supported by citations?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Metabolic disease, mechanism underlying diabetic complications, cancer metabolism, natural product biochemistry</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-485258-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines</article-title>.
                        <source>
                            <italic>Rejuvenation Research</italic>
                        </source>.<year>2021</year>;<volume>24</volume>(<issue>4</issue>) :
                        <elocation-id>10.1089/rej.2021.0009</elocation-id>
                        <fpage>310</fpage>-<lpage>318</lpage>
                        <pub-id pub-id-type="doi">10.1089/rej.2021.0009</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
</article>
